Dabney R - Search Results

Year	Number of Results
1952	3
1953	5
1954	3
1955	3
1956	2
1963	1
1964	1
1993	1
2013	1
2014	1
2017	1
2018	2
2019	4
2022	1
2023	3
2024	1
2025	1

1

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.

Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R, Kaufman M, Kirtane K, McBride SM, Old MO, Rooper L, Saba NF, Sheth S, Subramaniam RM, Wise-Draper TM, Wong D, Mell LK. Yilmaz E, et al. Among authors: dabney r. J Clin Oncol. 2023 Feb 10;41(5):1132-1146. doi: 10.1200/JCO.22.02328. Epub 2022 Dec 15. J Clin Oncol. 2023. PMID: 36521102 Review.

2

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.

Khurshid H, Ismaila N, Bian J, Dabney R, Das M, Ellis P, Feldman J, Hann C, Kulkarni S, Laskin J, Manochakian R, Mishra DR, Preeshagul I, Reddy P, Saxena A, Weinberg F, Kalemkerian GP. Khurshid H, et al. Among authors: dabney r. J Clin Oncol. 2023 Dec 10;41(35):5448-5472. doi: 10.1200/JCO.23.01435. Epub 2023 Oct 11. J Clin Oncol. 2023. PMID: 37820295

3

New agents in renal cell carcinoma.

Dabney R, Devine R, Sein N, George B. Dabney R, et al. Target Oncol. 2014 Sep;9(3):183-93. doi: 10.1007/s11523-013-0303-8. Epub 2013 Nov 16. Target Oncol. 2014. PMID: 24243495 Review.

4

Stereotactic body radiation therapy and immunotherapy.

Khalife M, Shahid K, Dabney RS, Phan AT. Khalife M, et al. Among authors: dabney rs. Clin Adv Hematol Oncol. 2019 Sep;17(9):518-523. Clin Adv Hematol Oncol. 2019. PMID: 31549973 Review.

5

Immunotherapy and targeted therapy-the new roadmap in cancer treatment.

Shahid K, Khalife M, Dabney R, Phan AT. Shahid K, et al. Among authors: dabney r. Ann Transl Med. 2019 Oct;7(20):595. doi: 10.21037/atm.2019.05.58. Ann Transl Med. 2019. PMID: 31807576 Free PMC article. Review.

6

Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.

Kalemkerian GP, Khurshid H, Ismaila N; Systemic Therapy for Small Cell Lung Cancer Guideline Expert Panel. Kalemkerian GP, et al. J Clin Oncol. 2025 Jan;43(1):101-105. doi: 10.1200/JCO-24-02245. Epub 2024 Nov 20. J Clin Oncol. 2025. PMID: 39565968 Review.

7

Molecular pathways and targeted therapy in cholangiocarcinoma.

Dabney RS, Khalife M, Shahid K, Phan AT. Dabney RS, et al. Clin Adv Hematol Oncol. 2019 Nov;17(11):630-637. Clin Adv Hematol Oncol. 2019. PMID: 31851165 Review.

8

Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids.

Yasmin-Karim S, Moreau M, Mueller R, Sinha N, Dabney R, Herman A, Ngwa W. Yasmin-Karim S, et al. Among authors: dabney r. Front Oncol. 2018 Apr 24;8:114. doi: 10.3389/fonc.2018.00114. eCollection 2018. Front Oncol. 2018. PMID: 29740535 Free PMC article.

9

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A.

Yilmaz E, Ismaila N, Dabney R, Saba NF, Mell LK. Yilmaz E, et al. Among authors: dabney r. JCO Oncol Pract. 2023 Apr;19(4):194-196. doi: 10.1200/OP.22.00802. Epub 2023 Jan 26. JCO Oncol Pract. 2023. PMID: 36701647 No abstract available.

10

Blue Cross.

DABNEY RH. DABNEY RH. Md State Med J. 1952 Jul;1(7):353. Md State Med J. 1952. PMID: 14956212 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year